Clinical trial
Focal Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia: A Prospective, Multicenter, Single-Arm Study in Mainland China
NCT05820035 is registered in ClinicalTrials.gov with Shanghai MicroPort EP MedTech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Focal Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia: A Prospective, Multicenter, Single-Arm Study in Mainland China
- Lead sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2023
- Completion date
- December 9, 2024
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrioventricular nodal reentrant tachycardia, atrioventricular reciprocating tachycardia, paroxysmal supraventricular tachycardia